Digital Therapeutics (DTx) Market to Reach USD 26 Billion by 2030, Driven by Rising Chronic Diseases and Technological Advancements

According to Next Move Strategy Consulting, Digital Therapeutics (DTx) Market is projected to grow at a CAGR of 27% from 2024 to 2030, reaching USD 26 billion by 2030. Digital therapeutics are evidence-based therapeutic interventions delivered via digital platforms such as mobile applications and software programs. These solutions provide interactive and personalized healthcare management for conditions such as mental health disorders, chronic diseases, and lifestyle-related ailments.

Click Here for Your FREE Sample!

Key Drivers of Growth

The increasing global burden of chronic diseases such as diabetes and cardiovascular conditions is fueling demand for digital therapeutics solutions. These solutions allow real-time tracking of critical health metrics such as blood glucose levels, physical activity, dietary habits, and medication adherence. By leveraging real-time data, digital therapeutics empower patients to proactively manage their health and enhance clinical outcomes.

According to a report by the International Diabetes Federation (IDF), the global diabetic population was 537 million adults (aged 20 to 79). This number is expected to reach 643 million by 2030 and 783 million by 2045, highlighting the increasing demand for digital therapeutics in diabetes management.

Additionally, technological advancements in wearable devices, mobile health applications, and data analytics have contributed to the growing adoption of digital therapeutics. These innovations enable remote patient monitoring, personalized treatment plans, and data-driven healthcare decisions, ultimately improving patient engagement and adherence.

Recent Market Developments

• AmerisourceBergen partnered with h2o Therapeutics to integrate digital therapeutics for Parkinson’s disease via the Parky mobile application. The partnership aims to enhance patient engagement through DTx Connect, AmerisourceBergen’s digital therapeutics platform.
• Omada Health Inc. partnered with Amazon to expand virtual healthcare access. This collaboration integrates remote monitoring and behavioral interventions, addressing chronic disease management through innovative digital solutions.
• AmerisourceBergen Corporation launched DTx Connect, a fully integrated platform for ordering, dispensing, and fulfilling digital therapeutics. The platform streamlines access to both prescription and non-prescription digital therapies through electronic medical record (EMR) systems.

Market Segmentation

The digital therapeutics market is segmented based on type, platform, therapeutic area, regulatory compliance, revenue model, distribution channel, and region:

• By Type: Devices, Software & Services
• By Platform: Desktop, Mobile, Tablet, Others
• By Therapeutic Area: Mental Health, Cognitive Health, Physical Health, Preventive Health, Chronic Disease Management, Others
• By Regulatory Compliance: FDA-Approved, CE Marked, Others
• By Revenue Model: Subscription-Based, Transaction-Based, Pay-Per-Use, Others
• By Distribution Channel: Direct Sales, Pharmacies, Online Platforms, Others

Regional Insights

North America Leads the Market

North America holds the largest share in the DTx market and is expected to maintain its dominance throughout the forecast period. This growth is attributed to the rising number of diabetic patients and the widespread adoption of DTx solutions for real-time monitoring.

According to the IDF, diabetes cases in North America are projected to increase from 57 million by 2030 and 63 million by 2045, further emphasizing the need for innovative digital interventions.

Moreover, the presence of leading DTx companies such as Omada Health Inc., AmerisourceBergen Corporation, and Fitbit Health Solutions further accelerates market expansion. These companies are actively launching new products and expanding their service offerings to cater to the growing demand for digital health solutions.

Competitive Landscape

The global DTx market is highly competitive, with key players focusing on strategic partnerships, acquisitions, and product innovations to maintain their market position. Major players include:

• Omada Health Inc.
• Welldoc, Inc.
• Fitbit Health Solutions
• Canary Health
• Lupin
• Noom
• CureApp, Inc.
• Propeller Health
• Brain+ A/S
• Pear Therapeutics, Inc.

Future Outlook

The digital therapeutics market is set to expand significantly, driven by increasing awareness, improved healthcare accessibility, and the continuous evolution of digital health technologies. The adoption of artificial intelligence (AI), machine learning (ML), and advanced analytics is expected to further revolutionize the sector, enhancing personalized healthcare delivery and improving patient outcomes.

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analysed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations within dusty experts across a diverse range of industry sectors. The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enable them to move beyond time and have competitive edge in the industry.

We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solutions that range from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.

Summary

The global digital therapeutics (DTx) market USD 26 billion by 2030, at a CAGR of 27%. This growth is fueled by the rising prevalence of chronic diseases, technological advancements, and increasing adoption of digital healthcare solutions. North America remains the dominant market, with companies investing in partnerships and innovative product launches. As digital therapeutics continues to revolutionize healthcare delivery, they offer a promising future in chronic disease management, mental health, and personalized medicine.